Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Dr Reddy’s Laboratories ( (RDY) ) has shared an update.
On February 4, 2025, Dr. Reddy’s Laboratories announced its participation in an investor conference scheduled for February 11, 2025, organized by Nuvama in Mumbai. The conference will involve in-person meetings with investor groups, potentially impacting the company’s investor relations and market position in the pharmaceutical industry.
More about Dr Reddy’s Laboratories
Dr. Reddy’s Laboratories is a pharmaceutical company based in Hyderabad, India. It focuses on providing a wide range of generic medications and active pharmaceutical ingredients (APIs) across various global markets.
YTD Price Performance: -11.81%
Average Trading Volume: 1,574,767
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $11.73B
For detailed information about RDY stock, go to TipRanks’ Stock Analysis page.
